Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in BLLN — BillionToOne, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to BLLN Full portfolio

Position in BLLN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,550,667
+$5,565,023 QoQ
Shares Held
54,598
+337.3% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#43
of 156 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BLLN Over Time

Shares Held

Position Value (USD)

Derivatives in BLLN

reported options exposure · as of Jun 30, 2026
CallValue
$3,251,458
CallShares
27,100
PutValue
$7,738,710
PutShares
64,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $350,142,810 across 32 Diagnostics & Research names. BLLN ranks #12 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 644,138 $96,640,024
2 DHR
Danaher Corp /De/
 225,380 $42,930,380
3 NTRA
Natera, Inc.
 133,758 $36,308,609
4 TMO
Thermo Fisher Scientific Inc.
 69,202 $34,695,114
5 IDXX
Idexx Laboratories Inc /De
 54,439 $28,658,866
6 IQV
Iqvia Holdings Inc.
 82,213 $15,885,195
7 ILMN
Illumina, Inc.
 67,131 $11,803,643
8 GRAL
GRAIL, Inc.
 155,295 $10,601,989

All Filings in BLLN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,738,710 64,500
2026-06-30 $3,251,458 27,100
2026-06-30 $6,550,667 54,598
2026-03-31 $1,957,712 24,800
2026-03-31 $1,097,266 13,900
2026-03-31 $985,644 12,486